Background: Baroreflex activation therapy (BAT) is a novel treatment for heart failure with reduced ejection fraction (HFrEF) in patients who remain symptomatic despite optimal medical therapy (OMT) and who are unsuitable for cardiac resynchronization therapy (CRT). BAT modulates the autonomic nervous system by electrically stimulating carotid baroreceptors, thus potentially improving heart function and symptoms.
Cases Summary: Two male HFrEF patients with nonischemic cardiomyopathy, symptomatic (NYHA functional class III) despite OMT, underwent successful BAT implantation. Patient 1, a 41-year-old man with a left ventricular ejection fraction (LVEF) of 34%, and patient 2, a 49-year-old man with an LVEF of 21%, showed significant improvements at 2-year follow-up, including increased LVEF, reduced N-terminal pro-B-type natriuretic peptide, better exercise capacity, and symptomatic relief (NYHA functional class II). Both patients avoided hospital readmissions and had no complications.
Discussion: This case series demonstrates BAT's potential for improving clinical outcomes in HFrEF patients ineligible for CRT. Further research is necessary to confirm these findings in larger groups.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jaccas.2024.103090 | DOI Listing |
Life Sci
March 2025
Department of Physiology, Hebei Medical University, 050017, Hebei, China; The Key Laboratory of Neural and Vascular Biology, Ministry of Education, 050017, Hebei, China; Hebei Key Laboratory of Cardiovascular Homeostasis and Aging, 050017, Hebei, China. Electronic address:
Aims: The present study aimed to investigate the direct link between trimethylamine N-oxide (TMAO) and diastolic dysfunction in heart failure with preserved ejection fraction (HFpEF).
Materials And Methods: Diastolic dysfunction is the main manifestation of HFpEF, so the "two-hit" mouse HFpEF model are used. After treated with high-fat diet (HFD) and N-nitro-l-arginine methyl ester (L-NAME) for 8 weeks, the cardiac function, myocardial fibrosis, oxidative stress levels, and molecular alterations were assessed.
J Ayurveda Integr Med
March 2025
Physiotherapy Department, Madhavbaug Khopoli Cardiac Hospital, Thane, Maharashtra, India.
Background: Management of Chronic Heart Failure (CHF) is quite challenging, and its prognosis remains poor. Thus, alternative and conventional treatment approaches with lifestyle modifications are needed to enhance the quality of life. One such approach is heart failure reversal treatment (HFRT) that includes Snehana (massage), Swedana (fomentation therapy), Basti (per rectal drug administration), and Hridaydhara.
View Article and Find Full Text PDFHeart Lung
March 2025
Depertment of Pulmonary Diseases, Ataturk University School of Medicine, Yakutiye, Erzurum, Turkey.
Background: Apelins are adipokines known for their anti-inflammatory, vasodilator, and antiatherosclerotic effects. They are involved in the pathogenesis of chronic diseases like chronic obstructive pulmonary disease (COPD) and coronary artery disease (CAD).
Objectives: This study aims to investigate apelin as a potential biomarker for early diagnosis and management of CAD in COPD patients.
Echocardiography
March 2025
Department of Physical Therapy, Faculty of Health Science, Kyorin University, Mitaka City, Tokyo, Japan.
Purpose: Central hypovolemia is considered to lead to a compensatory increase in cardiac contractility. From a physiological perspective, left ventricular (LV) twisting motion, which plays an important role in maintaining cardiac output, should be enhanced during central hypovolemia, but previous studies have shown inconsistent findings. Using 3D echocardiography, we tested the hypothesis that the LV twisting and untwisting motion would be enhanced during severe central hypovolemia.
View Article and Find Full Text PDFJpn J Radiol
March 2025
Department of Mechanical Engineering, Koc University, Istanbul, Turkey.
Purpose: In patients with repaired tetralogy of Fallot, transcatheter or surgical pulmonary valve replacement is recommended. However, it is not clear whether pulmonary valve replacement preserves systolic and diastolic functions of both ventricles. The aim of the study is to investigate the impact of transcatheter pulmonary valve replacement on atrial and ventricular myocardial strain changes by feature-tracking cardiac magnetic resonance imaging.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!